---
category: news
title: "KidneyIntelX™ Enables Monitoring of SGLT2 Inhibitor Therapy Response and Corresponding Risk Reduction Over Time"
excerpt: "Renalytix plc (LSE: RENX) (NASDAQ: RNLX) announces new data demonstrating KidneyIntelX™ can be effective at monitoring therapeutic response and improvements in kidney health over time in adults with type 2 diabetes."
publishedDateTime: 2021-06-28T06:00:00Z
originalUrl: "https://www.morningstar.com/news/globe-newswire/8271199/kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time"
webUrl: "https://www.morningstar.com/news/globe-newswire/8271199/kidneyintelx-enables-monitoring-of-sglt2-inhibitor-therapy-response-and-corresponding-risk-reduction-over-time"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Morningstar, Inc.
  domain: morningstar.com

topics:
  - AI in Healthcare
  - AI

secured: "fObr3Jm00QaS2z59NvXZx3hvWEKXeSiOW3o9v1gqo4HoU3ozN9+zLTBe/ihe00xi9B3WmOnMFWAP+ZNxtO4CkBcCt33AfZ84IeFng58HUoz9RPnQzT+peE3LWBQBn/HfWY0m5quLM3m8RG2EPGQqb8XpLJAcpnBTld8wEfs8KjIx4Uu2AFOVhU49xGKhEPNHC584FwKHCK026GEsAIk77x6IAkRin+0rHqy0izXwJMunRs30IlXjC+tVAic+u2nPqgnesVLU6J8mJocPC7F3lJY3U/+nxSpoo84OPDytJtAiVPT25eKtugF8m3Z0CTVT9bBTFV6g3NMGYIeX8dkrI0UTCTcw3geSfOejCXji2fo=;ScOS4MZ+Rx2g8h37sdl7cw=="
---

